Phase I/II Study of High Dose Irinotecan (Camptosar, CPT-11) in Patients With Recurrent Unresectable Malignant Glioma on Steroids/Anti-Epileptics.
Phase of Trial: Phase I/II
Latest Information Update: 26 Jan 2010
At a glance
- Drugs Irinotecan (Primary)
- Indications Glioma
- Focus Adverse reactions; Therapeutic Use
- 27 Jan 2009 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 03 Aug 2006 New trial record.